Showing 1,337 news articles about Finance & funding

Filters Content type: Editors' picks Topic: Finance & funding

News and information about funding, investment, budgets, commissioning, donors, economics and cost-effectiveness.

Undetectable viral load & treatment as prevention

Treatment as prevention: The value of early treatment of HIV infection

Editor's pick
The Incidental Economist
19 March 2014
Hepatitis C treatment

Hepatitis C treatments: Australia urged to subsidise 'revolutionary' new drugs

Editor's pick
ABC Online
18 March 2014
Hepatitis C treatment

Price of new hepatitis C drug questioned by U.S. medical experts

Editor's pick
CBC News
12 March 2014
Finance & funding

Cutbacks threaten Lesotho's HIV sufferers

Editor's pick
Deutsche Welle
11 March 2014
Global health initiatives

Ukraine activists seek stability in HIV/TB funding in face of political turmoil

Editor's pick
Global Fund Observer
7 March 2014
Hepatitis C treatment

Could new hepatitis C drugs bust state budgets?

Editor's pick
USA Today
4 March 2014
Hepatitis C treatment

Treating HCV -- Is the Price Right?

Editor's pick
Med Page Today
19 February 2014
New & experimental hepatitis C treatment

Gilead's CEO Says New Hepatitis C Drug Attracts Payers

Editor's pick
Bloomberg Businessweek
13 February 2014
The search for an HIV prevention vaccine

Crowd-funded HIV vaccine project sparks debate

Editor's pick
Nature
11 February 2014
Access to healthcare

Strategies for Health Insurers to Optimize Coverage for People with HIV

Editor's pick
HIV Medicine Association
10 February 2014
History of HIV & AIDS

Making PEPFAR: A Triumph of Medical Diplomacy

Editor's pick
Science & Diplomacy
7 February 2014
Finance & funding

Fair Pricing Coalition Highlights Major Barriers to Life-Saving Treatment in Affordable Care Act Health Insurance Marketplace Plans

Editor's pick
Fair Pricing Coalition
7 February 2014
Finance & funding

South African Billionaire Patrice Motsepe Gives $10 Million To Fight HIV/AIDS

Editor's pick
Forbes
28 January 2014
Access to healthcare

At $84000 Gilead Hepatitis C Drug Sets Off Payer Revolt

Editor's pick
Bloomberg
27 January 2014
Global health initiatives

PEPFAR transition to South Africa ‘country ownership’ disrupts care, threatens progress, squanders success, Health GAP report says

Editor's pick
Science Speaks
17 January 2014
New & experimental hepatitis C treatment

What Is a Hepatitis C Drug Worth?

Editor's pick
Roll Call
14 January 2014
Global health initiatives

Fitting AIDS into the post-2015 agenda

Editor's pick
Devex
14 January 2014
New & experimental hepatitis C treatment

Analysis: Fight for cheap drugs shifts from AIDS to new hepatitis pills

Editor's pick
Reuters
16 December 2013
Access to healthcare

US: Group Says Plans Discourage HIV Patients

Editor's pick
Wall Street Journal
12 December 2013
New & experimental hepatitis C treatment

Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large

Editor's pick
Forbes
11 December 2013
New & experimental hepatitis C treatment

Express Scripts Pushes Price Competition for Gilead Drug

Editor's pick
Bloomberg
11 December 2013
Finance & funding

New report from FCAA and UNAIDS shows little change in philanthropic funding for HIV in recent years

Editor's pick
UNAIDS
11 December 2013
Finance & funding

New way to finance health in world's less developed nations

Editor's pick
Eurekalert Medicine & Health
11 December 2013
Finance & funding

Romania spends too much on AIDS, says minister

Editor's pick
France 24
10 December 2013